A.O.U. di Bologna Policlinico S.Orsola Malpighi

Bologna, Emilia-Romagna 40138

0 studies enrolling now · 5 studies all time

What they study most

Chronic Heart Failure With Preserved Ejection Fraction, Chronic Kidney Disease, End-stage Renal Disease, Hemodiafiltration, Hemodialysis, Neoplasms, Prevention of Thromboembolic Events, Solid Tumors Harboring NTRK Fusion, Type 2 Diabetes Mellitus

Studies at this site

• A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid Tumors — Completed
• An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substances in the Blood Used as Indicators of Biological Processes, Disease Processes or Responses to Medication) and Finerenone in FIGARO-DKD Participants — Completed
• Study to Investigate the Safety of a Drug Called Osocimab at Low and High Doses in Adult Patients With Kidney Failure Requiring Regular Hemodialysis — Completed
• Phase 1b Multi-indication Study of Anetumab Ravtansine in Mesothelin Expressing Advanced Solid Tumors — Completed
• Patient-reported Outcomes in Vericiguat-treated Patients With HFpEF — Completed